For those who are interested, there’s a very readable article on the Bloomberg web site today entitled “What if what you ’survived’ wasn’t cancer?” The author expands on the idea that we might want to be reconsidering the importance of early detection of low-risk forms of “cancer” and the taxonomy of the word “cancer” itself.
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
One Response
Leave a Reply Cancel reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer
- PSA doubling time and prognosis for men with nmCRPC
- COVID-19 and prostate cancer management
- Sexual function and ways to maintain it while on ADT
- Prostate cancer treatment and quality of life in the “real world”
- Webinar series on active surveillance
- Do you have ADVANCED prostate cancer?
- Does “AR gain” affect responses to drugs like abiraterone in men with CRPC?
- New guidelines for management of advanced prostate cancer
- The pros and cons of “screening” for prostate cancer
- More on familial and hereditary risk for prostate cancer
- Putting on weight … if you’ve had localized prostate cancer
- Ipatasertib meets one of two primary endpoints in Phase III trial
- RP vs. RT as first-line treatment for prostate cancer: that word “may” again
- Germline testing to assess risk for specific types of prostate cancer
… and Archives
Blog at WordPress.com. WP Designer.
So glad to see this issue emerging in mainstream media. While over-diagnosis is a great way to sell a lot of product, the cost in pain, suffering, diminished wealth, and quality of life are very, very real. Further, cancer over-diagnosis is an unsustainable business model at the public health and healthcare financing levels.
Alas, the desire to buy and sell snake oil seems endemic to the human condition. Perhaps we can just shift to a format without such long-term consequences for those who take the bait.